Meeting
2021 Genitourinary Cancers Symposium
Efficacy of immune checkpoint blockade in patients with advanced upper tract urothelial cancer and mismatch repair deficiency or microsatellite instability (MSI).
Authors
Alexander Andreev-Drakhlin
MDA, Houston, TX
Alexander Andreev-Drakhlin , Amishi Yogesh Shah , Ana Cecilia Adriazola , Leah Shaw , Lidia Lopez , Marihella James , Surena F. Matin , Omar Alhalabi , Jianjun Gao , Arlene O. Siefker-Radtke , Sangeeta Goswami , Lianchun Xiao , Aradhana M. Venkatesan , Matthew T Campbell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 487)
DOI
10.1200/JCO.2021.39.6_suppl.487
Abstract #
487
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Updated efficacy and safety results of the ongoing non-interventional study (NIS) VARGADO (NCT02392455).
First Author: Christian Grohé
Poster
2020 Genitourinary Cancers Symposium
Avelumab as single agent for patients with metastatic or locally advanced urothelial cancer PD-L1+ unfit for cisplatin: The ARIES study.
First Author: Roberto Iacovelli
Poster
2019 ASCO Annual Meeting
Nintedanib plus docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Preliminary efficacy and safety results of the non-interventional study VARGADO.
First Author: Christian Grohé
First Author: Igor Tsaur